These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 38159830)
1. Therapy and guideline adherence at a multidisciplinary hypertension clinic: A prospective, observational study. Hias J; Defieuw L; Vanassche T; Verhamme P; Van der Linden L Vascul Pharmacol; 2024 Mar; 154():107271. PubMed ID: 38159830 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of prescriber responses to pharmacist recommendations communicated by fax in a medication therapy management program (MTMP). Perera PN; Guy MC; Sweaney AM; Boesen KP J Manag Care Pharm; 2011 Jun; 17(5):345-54. PubMed ID: 21657804 [TBL] [Abstract][Full Text] [Related]
3. Opportunities of Amlodipine as a Potential Candidate in the Evaluation of Drug Compliance during Antihypertensive Therapy. Kustovs D; Urtāne I; Sevostjanovs E; Moreino E; Trušinskis K Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837543 [No Abstract] [Full Text] [Related]
4. Pharmacist intervention program to enhance hypertension control: a randomised controlled trial. Morgado M; Rolo S; Castelo-Branco M Int J Clin Pharm; 2011 Feb; 33(1):132-40. PubMed ID: 21365405 [TBL] [Abstract][Full Text] [Related]
5. Impact of a pill box clinic to improve systolic blood pressure in veterans with uncontrolled hypertension taking 3 or more antihypertensive medications. Porter AK; Taylor SR; Yabut AH; Al-Achi A J Manag Care Spec Pharm; 2014 Sep; 20(9):905-11. PubMed ID: 25166289 [TBL] [Abstract][Full Text] [Related]
6. The (cost-)effectiveness of a patient-tailored intervention programme to enhance adherence to antihypertensive medication in community pharmacies: study protocol of a randomised controlled trial. van der Laan DM; Elders PJ; Boons CC; Bosmans JE; Nijpels G; Hugtenburg JG Trials; 2017 Jan; 18(1):29. PubMed ID: 28103948 [TBL] [Abstract][Full Text] [Related]
7. Adherence to the 2017 Clinical Practice Guidelines for Pediatric Hypertension in Safety-Net Clinics. Carroll AJ; Tedla YG; Padilla R; Jain A; Segovia E; Moin A; Wallace AS; Sanuade OA; Langman CB; Mohanty N; Smith JD JAMA Netw Open; 2023 Apr; 6(4):e237043. PubMed ID: 37058305 [TBL] [Abstract][Full Text] [Related]
9. Adherence to triple-component antihypertensive regimens is higher with single-pill than equivalent two-pill regimens: A randomized controlled trial. Sung J; Ahn KT; Cho BR; Lee SY; Kim BJ; Kim DK; Park JI; Lee WS Clin Transl Sci; 2021 May; 14(3):1185-1192. PubMed ID: 33503302 [TBL] [Abstract][Full Text] [Related]
11. Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility study. Chang AR; Evans M; Yule C; Bohn L; Young A; Lewis M; Graboski E; Gerdy B; Ehmann W; Brady J; Lawrence L; Antunes N; Green J; Snyder S; Kirchner HL; Grams M; Perkins R BMC Nephrol; 2016 Nov; 17(1):168. PubMed ID: 27825313 [TBL] [Abstract][Full Text] [Related]
12. Highlights of ESC/ESH 2018 Guidelines on the Management of Hypertension: What Every Doctor Should Know. Volpe M; Gallo G; Battistoni A; Tocci G High Blood Press Cardiovasc Prev; 2019 Feb; 26(1):1-8. PubMed ID: 30604199 [TBL] [Abstract][Full Text] [Related]
13. Assessment of prescribing, dispensing, and patient use pattern of antihypertensive drugs for patients attending outpatient department of Hiwot Fana Specialized University Hospital, Harar, Eastern Ethiopia. Shukrala F; Gabriel T Drug Des Devel Ther; 2015; 9():519-23. PubMed ID: 25632220 [TBL] [Abstract][Full Text] [Related]
14. Process- and patient-reported outcomes of a multifaceted medication adherence intervention for hypertensive patients in secondary care. Hedegaard U; Hallas J; Ravn-Nielsen LV; Kjeldsen LJ Res Social Adm Pharm; 2016; 12(2):302-18. PubMed ID: 26088274 [TBL] [Abstract][Full Text] [Related]
15. Patient, clinician and logistic barriers to blood pressure control among adult hypertensives in rural district hospitals in Rwanda: a cross-sectional study. Sibomana JP; McNamara RL; Walker TD BMC Cardiovasc Disord; 2019 Oct; 19(1):231. PubMed ID: 31638907 [TBL] [Abstract][Full Text] [Related]
16. Impact of single-pill combination therapy on adherence, blood pressure control, and clinical outcomes: a rapid evidence assessment of recent literature. Tsioufis K; Kreutz R; Sykara G; van Vugt J; Hassan T J Hypertens; 2020 Jun; 38(6):1016-1028. PubMed ID: 32371789 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of community pharmacist-provided telephone interventions to improve adherence to hypertension and diabetes medications. Stanton-Robinson C; Al-Jumaili AA; Jackson A; Catney C; Veach S; Witry MJ J Am Pharm Assoc (2003); 2018; 58(4S):S120-S124. PubMed ID: 29891173 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness of a Fixed-Dose, Single-Pill Combination of Perindopril and Amlodipine in Patients with Hypertension: A Non-Interventional Study. Fleig SV; Weger B; Haller H; Limbourg FP Adv Ther; 2018 Mar; 35(3):353-366. PubMed ID: 29498018 [TBL] [Abstract][Full Text] [Related]
19. Targeted and tailored pharmacist-led intervention to improve adherence to antihypertensive drugs among patients with type 2 diabetes in Indonesia: study protocol of a cluster randomised controlled trial. Alfian SD; Abdulah R; Denig P; van Boven JFM; Hak E BMJ Open; 2020 Jan; 10(1):e034507. PubMed ID: 31911526 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension. Isetts BJ; Buffington DE; Carter BL; Smith M; Polgreen LA; James PA Pharmacotherapy; 2016 Apr; 36(4):374-84. PubMed ID: 26893135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]